In Person Special Seminar: Connexin 43: A New Player in Duchenne Muscular Dystrophy and Associated Cardiomyopathy
Diego Fraidenraich, Ph.D., FAHA
Associate Professor
Cell Biology and Molecular Medicine
New Jersey Medical School
Rutgers University
In Person Seminar: Connexin 43: A New Player in Duchenne Muscular Dystrophy and Associated Cardiomyopathy
Date: Jan. 5, 2023
Time: 11 a.m.
Location: Room R3012, 2 Riverside Circle
About this Seminar
Aberrant expression of the cardiac gap junction protein connexin-43 (Cx43) has been suggested as playing a role in the development of cardiac disease in the mdx mouse model of Duchenne muscular dystrophy (DMD); however, a mechanistic understanding of this association is lacking. Here, Dr. Fraidenraich and his team identified a reduction of phosphorylation of Cx43 serines S325/S328/S330 in human and mouse DMD hearts. The team hypothesized that hypophosphorylation of Cx43 serine-triplet triggers pathological Cx43 redistribution to the lateral sides of cardiomyocytes (remodeling). Therefore, they generated knockin mdx mice in which the Cx43 serine-triplet was replaced with either phospho-mimicking glutamic acids (mdxS3E) or nonphosphorylatable alanines (mdxS3A). The mdxS3E, but not mdxS3A, mice were resistant to Cx43 remodeling, with a corresponding reduction of Cx43 hemichannel activity. MdxS3E cardiomyocytes displayed improved intracellular Ca2+ signaling and a reduction of NADPH oxidase 2 (NOX2)/ROS production. Furthermore, mdxS3E mice were protected against inducible arrhythmias, related lethality, and the development of cardiomyopathy. Inhibition of microtubule polymerization by colchicine reduced both NOX2/ROS and oxidized CaMKII, increased S325/S328/S330 phosphorylation, and prevented Cx43 remodeling in mdx hearts. Together, these results demonstrate a mechanism of dystrophic Cx43 remodeling and suggest that targeting Cx43 may be a therapeutic strategy for preventing heart dysfunction and arrhythmias in DMD patients.
You May Also Be Interested In...
-
Home ItemCANCELLED: In Person Seminar: Circadian Clocks in Skeletal Muscle; Contributions to Systemic Health , home
March 29, 2024, 11:00 a.m. | Karyn Esser, Ph.D., Professor and Chair, Physiology and Aging, University of Florida College of Medicine | Co-Sponsored by the Fralin Biomedical Research Institute Center for Exercise Medicine Research
-
Home ItemThe Impact of Climate Change on Vulnerable Populations: What Can Be Done? , home
April 4, 2024, 5:30 p.m. (Reception at 5 p.m.) | Zulfiqar Bhutta, Ph.D., Robert Harding Inaugural Chair in Global Child Health, Hospital for Sick Children, Professor, Department of Paediatrics, Nutritional Sciences and Public Health, University of Toronto | Maury Strauss Distinguished Public Lecture
-
Home ItemIn Person Seminar: The Meaning of Dopamine , home
April 5, 2024, 11:00 a.m. | Henry Yin, Ph.D., Professor, Psychology and Neuroscience, Duke University School of Medicine | Co-Sponsored by the Fralin Biomedical Research Institute Center for Neurobiology Research
-
Home ItemWhat is Alzheimer's Disease and Can We Prevent It? , home
April 11, 2024, 5:30 p.m. (Reception at 5 p.m.) | Kristine Yaffe, M.D., Professor and Roy and Marie Scola Endowed Chair of Psychiatry, Neurology, and Epidemiology, Director, Center for Population Brain Health, University of California, San Francisco, Member, National Academy of Medicine | Maury Strauss Distinguished Public Lecture
-
Home ItemIn Person Seminar: Addiction Recovery: From Culture to Science , home
April 12, 2024, 11:00 a.m. | John Kelly, Ph.D., Elizabeth R. Spallin Professor of Psychiatry in Addiction Medicine, Harvard Medical School | Co-Sponsored by the Fralin Biomedical Research Institute Center for Health Behaviors Research and the Addiction Recovery Research Center
-
Home ItemIn Person at CNRIC: Hyperactivation of an RNA Binding Protein by Cancer-associated Mutations , home
April 19, 11:00 a.m., Collaboratory, Children's National Research and Innovation Campus, Washington, D.C. | Daniel Dominguez, Ph.D., Assistant Professor, Pharmacology, UNC School of Medicine | Co-Sponsored by the Fralin Biomedical Research Institute Cancer Research Group